INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Dec 13, 2013 |
VP Strategy and Investor Relat
Trans History: 164
|
VP Strategy and Investor Relat | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 30,000 |
Jan 02, 2013 |
SVP Clin Devel & Reg Affairs
Trans History: 208
|
SVP Clin Devel & Reg Affairs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 30,000 | $21.25 | 44,990 |
Jan 02, 2013 |
SVP Clin Devel & Reg Affairs
Trans History: 208
|
SVP Clin Devel & Reg Affairs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 30,000 | -- | 295 |
Dec 14, 2012 |
SVP Clin Devel & Reg Affairs
Trans History: 208
|
SVP Clin Devel & Reg Affairs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 44,543 |
Dec 14, 2012 |
VP Regulat Dev & Med Safety
Trans History: 288
|
VP Regulat Dev & Med Safety | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 30,000 |
Oct 25, 2012 |
SVP & General Mgr Industrial O
Trans History: 359
|
SVP & General Mgr Industrial O | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 30,000 | $21.92 | 39,568 |
Oct 25, 2012 |
SVP & General Mgr Industrial O
Trans History: 359
|
SVP & General Mgr Industrial O | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 30,000 | -- | -- |
Dec 16, 2011 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 45,000 |
Dec 14, 2010 |
VP, Strat and Invest Relations
Trans History: 164
|
VP, Strat and Invest Relations | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 30,000 |
Dec 14, 2010 |
SVP F&A, CFO, Treas & Asst Sec
Trans History: 645
|
SVP F&A, CFO, Treas & Asst Sec | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 73,734 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.